Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Fungal Infection Reports
Published in: Current Fungal Infection Reports 1/2014

01-03-2014 | Current Management of Fungal Infections (L Ostrosky-Zeichner, Section Editor)

Diagnosis of Candidemia

Authors: Roxana G. Vitale, Marcio Nucci

Published in: Current Fungal Infection Reports | Issue 1/2014

Login to get access

Abstract

Patients with invasive fungal infections still have high morbidity and mortality despite an increasing number of antifungals and other therapies. Because of this problem, an accurate and rapid diagnosis is mandatory in order to improve clinical outcome in these patients. In this paper we review the tools for the diagnosis of candidemia, including blood culture systems, chromogenic media, commercial kits for species identification, and newer technologies for the diagnosis of candidemia such as MALDI-TOF, PNA FISH and the T2 system.
Literature
1.
•• Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011. Clin Infect Dis. 2012;55:1352–61. This population-based study investigated trends in the epidemiology of candidemia in two cities in the USA.PubMedCrossRef
2.
•• Nucci M, Queiroz-Telles F, Alvarado-Matute T, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One. 2013;8:e59373. This is the first study of the epidemiology of candidemia in Latin America.PubMedCentralPubMedCrossRef
3.
4.
Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43:25–31.PubMedCrossRef
5.
Morris AJ, Wilson SJ, Marx CE, Wilson ML, Mirrett S, Reller LB. Clinical impact of bacteria and fungi recovered only from broth cultures. J Clin Microbiol. 1995;33:161–5.PubMedCentralPubMed
6.
Roberts GD, Horstmeier C, Hall M, Washington JA. Recovery of yeast from vented blood culture bottles. J Clin Microbiol. 1975;2:18–20.PubMedCentralPubMed
7.
Kiehn TE, Capitolo C, Mayo JB, Armstrong D. Comparative recovery of fungi from biphasic and conventional blood culture media. J Clin Microbiol. 1981;14:681–3.PubMedCentralPubMed
8.
Kiehn TE, Wong B, Edwards FF, Armstrong D. Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol. 1983;18:300–4.PubMedCentralPubMed
9.
Morrell Jr RM, Wasilauskas BL, Steffee CH. Performance of fungal blood cultures by using the Isolator collection system: is it cost-effective? J Clin Microbiol. 1996;34:3040–3.PubMedCentralPubMed
10.
Durmaz G, Us T, Aydinli A, Kiremitci A, Kiraz N, Akgun Y. Optimum detection times for bacteria and yeast species with the BACTEC 9120 aerobic blood culture system: evaluation for a 5-year period in a Turkish university hospital. J Clin Microbiol. 2003;41:819–21.PubMedCentralPubMedCrossRef
11.
Horvath LL, Hospenthal DR, Murray CK, Dooley DP. Detection of simulated candidemia by the BACTEC 9240 system with plus aerobic/F and anaerobic/F blood culture bottles. J Clin Microbiol. 2003;41:4714–7.PubMedCentralPubMedCrossRef
12.
Horvath LL, George BJ, Murray CK, Harrison LS, Hospenthal DR. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection. J Clin Microbiol. 2004;42:115–8.PubMedCentralPubMedCrossRef
13.
Horvath LL, George BJ, Hospenthal DR. Detection of fifteen species of Candida in an automated blood culture system. J Clin Microbiol. 2007;45:3062–4.PubMedCentralPubMedCrossRef
14.
Cateau E, Cognee AS, Tran TC, et al. Impact of yeast-bacteria coinfection on the detection of Candida sp. in an automated blood culture system. Diagn Microbiol Infect Dis. 2012;72:328–31.PubMedCrossRef
15.
• Ericson EL, Klingspor L, Ullberg M, Ozenci V. Clinical comparison of the Bactec Mycosis IC/F, BacT/Alert FA, and BacT/Alert FN blood culture vials for the detection of candidemia. Diagn Microbiol Infect Dis. 2012;73:153–6. This study compared the two commercially available blood culture systems.PubMedCrossRef
16.
Sogaard M, Hjort U, Hojbjerg T, Schonheyder HC. Detection of candidaemia in high risk patients: can yield of blood cultures be improved by blind subculture? Scand J Infect Dis. 2006;38:187–91.PubMedCrossRef
17.
Lin HH, Liu YF, Tien N, Ho CM, Hsu LN, Lu JJ. Evaluation of the blood volume effect on the diagnosis of bacteremia in automated blood culture systems. J Microbiol Immunol Infect. 2013;46:48–52.PubMedCrossRef
18.
Sarkar S, Bhagat I, DeCristofaro JD, Wiswell TE, Spitzer AR. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis. J Perinatol. 2006;26:18–22.PubMedCrossRef
19.
Fernandez J, Erstad BL, Petty W, Nix DE. Time to positive culture and identification for Candida blood stream infections. Diagn Microbiol Infect Dis. 2009;64:402–7.PubMedCrossRef
20.
Murray MP, Zinchuk R, Larone DH. CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation-of-trehalose test. J Clin Microbiol. 2005;43:1210–2.PubMedCentralPubMedCrossRef
21.
Willinger B, Hillowoth C, Selitsch B, Manafi M. Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol. 2001;39:3793–5.PubMedCentralPubMedCrossRef
22.
Lees E, Barton RC. The use of Niger seed agar to screen for Candida dubliniensis in the clinical microbiology laboratory. Diagn Microbiol Infect Dis. 2003;46:13–7.PubMedCrossRef
23.
24.
Khan ZU, Ahmad S, Mokaddas E, Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol. 2004;42:4796–8.PubMedCentralPubMedCrossRef
25.
Chowdhary A, Randhawa HS, Kowshik T, Kathuria S, Roy P, Brandt ME. Application of hypertonic Sabouraud glucose agar for differentiation of Candida dubliniensis from Candida albicans. Diagn Microbiol Infect Dis. 2011;69:440–2.PubMedCrossRef
26.
Hof H, Eigner U, Maier T, Staib P. Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF mass spectrometry. Clin Lab. 2012;58:927–31.PubMed
27.
Ahmad S, Khan Z, Asadzadeh M, Theyyathel A, Chandy R. Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis. BMC Infect Dis. 2012;12:230.PubMedCentralPubMedCrossRef
28.
Campbell CK, Davey KG, Holmes AD, Szekely A, Warnock DW. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J Clin Microbiol. 1999;37:821–3.PubMedCentralPubMed
29.
Davey KG, Chant PM, Downer CS, Campbell CK, Warnock DW. Evaluation of the AUXACOLOR system, a new method of clinical yeast identification. J Clin Pathol. 1995;48:807–9.PubMedCentralPubMedCrossRef
30.
Freydiere AM, Guinet R, Boiron P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol. 2001;39:9–33.PubMedCrossRef
31.
32.
• Meletiadis J, Arabatzis M, Bompola M, et al. Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates. J Clin Microbiol. 2011;49:2722–7. This study compared the most frequently used commercial systems for identification of Candida species.PubMedCentralPubMedCrossRef
33.
La SB, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS One. 2009;4:e8041.CrossRef
34.
Christner M, Rohde H, Wolters M, Sobottka I, Wegscheider K, Aepfelbacher M. Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting. J Clin Microbiol. 2010;48:1584–91.PubMedCentralPubMedCrossRef
35.
Ferroni A, Suarez S, Beretti JL, et al. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2010;48:1542–8.PubMedCentralPubMedCrossRef
36.
Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect. 2011;17:1359–65.PubMed
37.
Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol. 2011;49:1614–6.PubMedCentralPubMedCrossRef
38.
Marklein G, Josten M, Klanke U, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol. 2009;47:2912–7.PubMedCentralPubMedCrossRef
39.
Hendrickx M, Goffinet JS, Swinne D, Detandt M. Screening of strains of the Candida parapsilosis group of the BCCM/IHEM collection by MALDI-TOF MS. Diagn Microbiol Infect Dis. 2011;70:544–8.PubMedCrossRef
40.
Schubert S, Weinert K, Wagner C, et al. Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. J Mol Diagn. 2011;13:701–6.PubMedCentralPubMedCrossRef
41.
Goyer M, Lucchi G, Ducoroy P, Vagner O, Bonnin A, Dalle F. Optimization of the preanalytical steps of matrix-assisted laser desorption ionization-time of flight mass spectrometry identification provides a flexible and efficient tool for identification of clinical yeast isolates in medical laboratories. J Clin Microbiol. 2012;50:3066–8.PubMedCentralPubMedCrossRef
42.
Farina C, Perin S, Andreoni S, et al. Evaluation of the peptide nucleic acid fluorescence in situ hybridisation technology for yeast identification directly from positive blood cultures: an Italian experience. Mycoses. 2012;55:388–92.PubMedCrossRef
43.
Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm. 2012;69:1910–4.PubMedCrossRef
44.
Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC. Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact. J Clin Microbiol. 2013;51:1301–2.PubMedCentralPubMedCrossRef
45.
Harris DM, Hata DJ. Rapid identification of bacteria and Candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study. Ann Clin Microbiol Antimicrob. 2013;12:2.PubMedCentralPubMedCrossRef
46.
Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5:182ra54.PubMed
47.
Metadata
Title
Diagnosis of Candidemia
Authors
Roxana G. Vitale
Marcio Nucci
Publication date
01-03-2014
Publisher
Springer US
Published in
Current Fungal Infection Reports / Issue 1/2014
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-013-0164-8

Other articles of this Issue 1/2014

Current Fungal Infection Reports 1/2014 Go to the issue

Pediatric Fungal Infections (T Lehrnbecher, Section Editor)

Physiology-Based Pharmacokinetic Modeling—Promise for Pediatric Drug Development?

Current Management of Fungal Infections (L Ostrosky-Zeichner, Section Editor)

Fungi as Eukaryotes: Understanding the Antifungal Effects of Immunosuppressive Drugs

Pediatric Fungal Infections (T Lehrnbecher, Section Editor)

Pneumocystis Pneumonia: Epidemiology and Options for Prophylaxis in Non-HIV Immunocompromised Pediatric Patients

Pediatric Fungal Infections (T Lehrnbecher, Section Editor)

Invasive Fungal Infections in the Child with Chronic Granulomatous Disease

Pediatric Fungal Infections (T Lehrnbecher, Section Editor)

Rare Fungal Infections in Children: An Updated Review of the Literature

Current Management of Fungal Infections (L Ostrosky-Zeichner, Section Editor)

Candida Sepsis: a New Entity?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits